Literature DB >> 26103159

The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012.

Juan P Brito1,2, Alaa Al Nofal3, Victor M Montori1,2, Ian D Hay1, John C Morris1.   

Abstract

BACKGROUND: An ongoing epidemic of thyroid carcinoma (TC) has affected Americans since 1975. Understanding the contribution of subclinical disease and the mechanism of such disease detection may help to alter the course of this epidemic.
METHODS: We used Rochester Epidemiology Project resources to examine the incidence of TC cases, disease specific mortality, and method of diagnosis during 1935 through 2012. During 2000-2012, we also extracted the mechanism of detection of clinically occult tumors.
RESULTS: The age-adjusted incidence (AAI) for TC increased from 7.1 [95% confidence interval (CI) 5.5-8.8] per 100,000 person-years (p-y) during 1990-1999 to 13.7 [CI 11.8-15.6] per 100,000 p-y during 2000-2012, with no change in disease-specific mortality since 1935. The incidence trend analysis stratified by the mechanism of detection revealed the AAI of clinically recognized TC was 5.5 per 100,000 p-y [CI 3.4-7.5] in 1960-1969, a rate similar to the incidence seen during 2000-2012. However, AAI of clinically occult TC increased from 0.2 per 100,000 p-y [CI 0.0-0.6] in 1935-1949 to 1.9 per 100,000 p-y [CI 1.2-2.9] in 1990-1999 and to 7.4 per 100,000 p-y [CI 6.0-8.8] in 2000-2012. During 2000-2012, the most frequent reasons for recognition of "occult" tumors were (1) incidental discovery during diagnostic neck imaging in 40 (19%), (2) pathology review of specimens from thyroid surgery for benign conditions in 29 (14%), and (3) investigations of patients with symptoms or palpable nodules that were clearly not associated with coexistent but occult TC but triggered the use of diagnostic neck imaging in 37 (27%).
CONCLUSIONS: In this population-based study conducted in Olmsted County, Minnesota, the rapid increased incidence of TC during 2000-2012 can be completely attributed to the increased diagnosis of occult TCs, which are mainly found through the use of diagnostic neck imaging. The incidence of clinical TC and disease-specific TC mortality remains stable since 1970, implying that the observed increased incidence is due to the increased detection of subclinical lesions.

Entities:  

Mesh:

Year:  2015        PMID: 26103159      PMCID: PMC4560845          DOI: 10.1089/thy.2014.0594

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  26 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  What to do with incidental thyroid nodules on imaging? An approach for the radiologist.

Authors:  Jenny K Hoang; Phillip Raduazo; David M Yousem; James D Eastwood
Journal:  Semin Ultrasound CT MR       Date:  2012-04       Impact factor: 1.875

3.  Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours.

Authors:  Juan P Brito; John C Morris; Victor M Montori
Journal:  BMJ       Date:  2013-08-27

4.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca
Journal:  Int J Epidemiol       Date:  2012-11-18       Impact factor: 7.196

5.  Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.

Authors:  Yasuhiro Ito; Akira Miyauchi; Minoru Kihara; Takuya Higashiyama; Kaoru Kobayashi; Akihiro Miya
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

6.  Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States.

Authors:  Julie Ann Sosa; John W Hanna; Karen A Robinson; Richard B Lanman
Journal:  Surgery       Date:  2013-10-02       Impact factor: 3.982

7.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.

Authors:  Scott Ramsey; David Blough; Anne Kirchhoff; Karma Kreizenbeck; Catherine Fedorenko; Kyle Snell; Polly Newcomb; William Hollingworth; Karen Overstreet
Journal:  Health Aff (Millwood)       Date:  2013-05-15       Impact factor: 6.301

8.  The clinical and economic burden of a sustained increase in thyroid cancer incidence.

Authors:  Briseis Aschebrook-Kilfoy; Rebecca B Schechter; Ya-Chen Tina Shih; Edwin L Kaplan; Brian C-H Chiu; Peter Angelos; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-15       Impact factor: 4.254

9.  Thyroid cancers detected by imaging are not necessarily small or early stage.

Authors:  Michael K Malone; Jonathan Zagzag; Jennifer B Ogilvie; Kepal N Patel; Keith S Heller
Journal:  Thyroid       Date:  2013-09-13       Impact factor: 6.568

10.  The increasing incidence of thyroid cancer: the influence of access to care.

Authors:  Luc G T Morris; Andrew G Sikora; Tor D Tosteson; Louise Davies
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

View more
  38 in total

1.  Thyroid cancer: Overdiagnosis of papillary carcinoma - who benefits?

Authors:  Juan P Brito; Ian D Hay
Journal:  Nat Rev Endocrinol       Date:  2017-01-06       Impact factor: 43.330

2.  Causes of referral to the first endocrine visit of patients with thyroid carcinoma in a mildly iodine-deficient area.

Authors:  Michela Marina; Gian Paolo Ceda; Raffaella Aldigeri; Graziano Ceresini
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

Review 3.  Evolving molecularly targeted therapies for advanced-stage thyroid cancers.

Authors:  Keith C Bible; Mabel Ryder
Journal:  Nat Rev Clin Oncol       Date:  2016-03-01       Impact factor: 66.675

Review 4.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

5.  Progress in Endocrine Neoplasia.

Authors:  Samuel A Wells
Journal:  Clin Cancer Res       Date:  2016-10-15       Impact factor: 12.531

Review 6.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

7.  Thyroid nodule ultrasound reports in routine clinical practice provide insufficient information to estimate risk of malignancy.

Authors:  Christopher John Symonds; Paula Seal; Sana Ghaznavi; Winson Y Cheung; Ralf Paschke
Journal:  Endocrine       Date:  2018-05-25       Impact factor: 3.633

8.  Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.

Authors:  Nazanene H Esfandiari; David T Hughes; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

9.  Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer.

Authors:  Megan R Haymart; Mousumi Banerjee; David Reyes-Gastelum; Elaine Caoili; Edward C Norton
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

10.  Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Authors:  R Michael Tuttle; James A Fagin; Gerald Minkowitz; Richard J Wong; Benjamin Roman; Snehal Patel; Brian Untch; Ian Ganly; Ashok R Shaha; Jatin P Shah; Mark Pace; Duan Li; Ariadne Bach; Oscar Lin; Adrian Whiting; Ronald Ghossein; Inigo Landa; Mona Sabra; Laura Boucai; Stephanie Fish; Luc G T Morris
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-10-01       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.